GFAP and early-onset autosomal dominant Alzheimer disease: Plasma GFAP began to increase 10 years before symptom onset, prior to P-tau181 and NfL, suggesting that GFAP is mirroring Alzheimer’s disease pathology upstream of tau phosphorylation and neurodegeneration.